Cochrane meta-analysis: teicoplanin versus vancomycin for proven or suspected infection
Objective: To compare efficacy and safety of vancomycin versusteicoplanin in patients with proven or suspected infection.Methods: Data Sources: Cochrane Renal Group’s SpecializedRegister, CENTRAL, MEDLINE, EMBASE, nephrology textbooksand review articles. Inclusion criteria: Randomized controlled tri...
Main Authors: | Diogo Diniz Gomes Bugano, Alexandre Biasi Cavalcanti, Anderson Roman Goncalves, Claudia Salvini de Almeida, Eliézer Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2011-09-01
|
Series: | Einstein (São Paulo) |
Subjects: | |
Online Access: | http://apps.einstein.br/revista/arquivos/PDF/Einstein_v9n3_265-282_ingles.pdf |
Similar Items
-
Teicoplanin non-susceptible coagulase-negative staphylococci in a large Australian healthcare network: Implications for treatment with vancomycin
by: W. R. P. L. I. Wijesooriya, et al.
Published: (2017-05-01) -
Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors
by: Byung-Keun Kim, et al.
Published: (2020-05-01) -
Rabeprazole.
by: Desai C, et al.
Published: (2002-01-01) -
Clinical practice and costs of treating catheter-related infections with teicoplanin or vancomycin
by: Simoens S, et al.
Published: (2006-06-01) -
Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia
by: Ana Paula Ferreira Nunes, et al.